Change - Announcement of Cessation::DEMISE OF MR TAI KOK CHUAN, INDEPENDENT DIRECTOR
Issuer & Securities
ARION ENTERTAINMENT SINGAPORE LIMITED
ARION ENTERTAINMENT SING LTD - SG2F80993502 - 5VU
ARION ENTERTAINMENTSIN W200505 - SG41S1000001 - 41RW
Change - Announcement of Cessation
Date &Time of Broadcast
Announcement Sub Title
DEMISE OF MR TAI KOK CHUAN, INDEPENDENT DIRECTOR
Submitted By (Co./ Ind. Name)
Ng Kai Man
Description (Please provide a detailed description of the event in the box below)
Demise of Mr Tai Kok Chuan, Independent Director
The information set out herein in respect of Mr Tai Kok Chuan is to the best belief and knowledge of the Company.
This announcement has been prepared by Arion Entertainment Singapore Limited (the "Company") and its contents have been reviewed by the Company's sponsor, PrimePartners Corporate Finance Pte. Ltd. (the "Sponsor") for compliance with the Singapore Exchange Securities Trading Limited (the "SGX-ST") Listing Manual Section B: Rules of Catalist (the "Catalist Rules"). The Sponsor has not verified the contents of this announcement.
This announcement has not been examined or approved by the SGX-ST. The Sponsor and the SGX-ST assume no responsibility for the contents of this announcement, including the accuracy, completeness or correctness of any of the information, statements or opinions made or reports contained in this announcement.
The contact person for the Sponsor is Ms Keng Yeng Pheng, Associate Director, Continuing Sponsorship (Mailing address: 16 Collyer Quay, #10-00 Income at Raffles, Singapore 049318 and E-mail: firstname.lastname@example.org).
Name Of Person
Tai Kok Chuan
Is effective date of cessation known?
If yes, please provide the date
Detailed Reason (s) for cessation
Passed away on 6 March 2018.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
Any other relevant information to be provided to shareholders of the listed issuer?
Date of Appointment to current position
Does the AC have a minimum of 3 members (taking into account this cessation)?
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Independent Director and Member of the Nominating Committee and Remuneration Committee.
Role and responsibilities
To perform the functions of Independent Director and fulfilling duties and responsibilities as a member of the Nominating Committee and Remuneration Committee.
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
Shareholding interest in the listed issuer and its subsidiaries?
Held 120,300,000 ordinary shares in the Company
Past (for the last 5 years)
TQAQI International Pte. Ltd.
China Medical (International) Group Limited
Albedo Corporation Pte. Ltd.
Albedo Sdn. Bhd.
iMyth Taiwan Limited
China iMyth (Hong Kong) Pte. Ltd.
China iMyth Company Pte. Ltd.
CMIC Hemodialysis Pte. Ltd.
China iMyth (Shanghai) Co., Ltd.
CMIC Hemodialysis (Hong Kong) Limited